Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYSZ2200009	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	License Renew	2022-03-04					view
JYSZ2200008	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	License Renew	2022-03-04					view
JYSB2400035	德谷胰岛素利拉鲁肽注射液	Insulin Degludec;Liraglutide	Injection	Biological Products(3.1)	Supplementary Application	2024-02-27		Novo Nordisk A/S			view
JYSB2400021	德谷胰岛素利拉鲁肽注射液	Insulin Degludec;Liraglutide	Injection	Biological Products	Supplementary Application	2024-02-01					view
JYSB2200188	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Supplementary Application	2022-09-29		Novo Nordisk A/S			view
JYSB2200187	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Supplementary Application	2022-09-29		Novo Nordisk A/S			view
JYSB2101167	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Supplementary Application	2021-11-10		Novo Nordisk A/S			view
JYSB2101166	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Supplementary Application	2021-11-10		Novo Nordisk A/S			view
JYSB2101153	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Supplementary Application	2021-10-22		Novo Nordisk A/S			view
JYSB2101152	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Supplementary Application	2021-10-22		Novo Nordisk A/S			view
JYSB1900259	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Supplementary Application	2019-09-18	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2020-04-21	view
JYSB1900258	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Supplementary Application	2019-09-18	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2020-04-21	view
JYSB1800142	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Supplementary Application	2018-07-30	诺和诺德（中国）制药有限公司	Novo Nordisk (China) Pharmaceuticals Co Ltd	Certificate Issued	2018-10-09	view
JYSB1800140	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Supplementary Application	2018-07-30	诺和诺德（中国）制药有限公司	Novo Nordisk (China) Pharmaceuticals Co Ltd	Certificate Issued	2018-10-09	view
JYSB1700223	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Supplementary Application	2017-12-18	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2018-01-10	view
JYSB1700222	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Supplementary Application	2017-12-18	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2018-01-10	view
JYSB1700181	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Supplementary Application	2017-10-16	诺和诺德（中国）制药有限公司	Novo Nordisk (China) Pharmaceuticals Co Ltd	Certificate Issued	2017-11-10	view
JYSB1700180	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Supplementary Application	2017-10-16	诺和诺德（中国）制药有限公司	Novo Nordisk (China) Pharmaceuticals Co Ltd	Certificate Issued	2017-11-10	view
JXSS2000037	德谷胰岛素利拉鲁肽注射液	Insulin Degludec;Liraglutide	Injection	Biological Products(3.1)	Import Drug Application	2020-09-30	诺和诺德（中国）制药有限公司	Novo Nordisk (China) Pharmaceuticals Co Ltd	Certificate Issued	2021-08-27	view
JXSS2000036	德谷胰岛素利拉鲁肽注射液	Insulin Degludec;Liraglutide	Injection	Biological Products(3.1)	Import Drug Application	2020-09-30	诺和诺德（中国）制药有限公司	Novo Nordisk (China) Pharmaceuticals Co Ltd	Certificate Issued	2021-10-28	view